12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15

12/6/2024Recent Executive Moves

12/5/2024Abbisko’s PRMT5*MTA Inhibitor ABSK131 Granted IND Clearance from the ...

12/5/2024Cinclus Wins Marketing Approval in China for GERD Drug Linaprazan Glur...

12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...

12/5/2024GSK and Zhifei Deepen Collaboration to Target RSV Vaccine Development

12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)

12/5/2024Big Pharma Doubles Down on China (The Wire China)

12/4/2024CDE Issues the List of Reference Formulations for GQCE Studies (85th B...

12/4/2024Everest Medicines Announces Positive Results in Preliminary Analysis o...

12/4/2024GSK Secures $1B Option Deal for DualityBio's Preclinical ADC

12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...

12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...

12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...

12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...

12/3/2024Signet Thera Secures Over CNY 70M to Advance Targeted Cancer Drug Deve...

12/3/2024NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...

12/3/2024HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...

12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...

12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong

12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...

12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  

12/2/2024Nanjing Leads Biolabs Files for Hong Kong IPO

12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...

12/2/2024Affinity Biopharma Raises Over CNY 400M in Series B2 to Advance Tumor-...

12/2/2024Shanghai Cell Therapy Group Submits Application Proof for Hong Kong Li...

12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...

12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia

12/2/2024Hangzhou Jiuyuan Gene Engineering Debuts on Hong Kong Stock Exchange

12/2/2024Allink Biotherapeutics Secures $42M Series A to Advance Oncology and I...

Page:38/777 Total number of articles:23289: [First][<<] [36] [37] [38] [39] [40] [>>] [End]